[
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "google/gemini-2.5-flash",
      "messages": [
        {
          "role": "user",
          "content": "The targets of some antibodies are proteo-glycans. One such antibody binds MUC1, but only if the threonine within one of MUC1's repeat sequences, GSTA, carries a TN antigen, a monosacharide of N-acetylgalactosamine. \nUsing published tools, you start to put together a system to study this antibody. Your MUC1 construct carries a flag tag and is expressed on the surface of C1GALT1 KO HEK293t cells that strictly produce TN O-glycans.  You were able to show that the sugar is essential to the interaction by using inhibitory concentrations of GalNAc (500 mM), as GalNAc inhibits the antibody's ability to bind when compared to PBS controls. In addition to verifying the surface expression of MUC1, why is it essential to include the anti-flag antibody, and to which step should it be added?\n\n\nAnswer Choices:\nA. No need, controls are good\nB. Anti-flag should be added with the secondary antibodies. Its included to control for potential off-target effects of the 500 mM GalNAc.\nC. Anti-flag should be added with the primary antibodies. Its included to verify GalNAc has not altered surface expression of MUC1\nD. Anti-flag should be added with the primary antibodies. Its included to control for potential off-target effects of the 500 mM GalNAc. \nE. Anti-flag should be added with the secondary antibodies. Its included to verify GalNAc has not altered surface expression of MUC1"
        }
      ],
      "reasoning": {
        "max_tokens": 8192
      },
      "reasoning_effort": null,
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762217067-x4l6f7A5w1k86A648LTx",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\n  \"answer\": \"Anti-flag should be added with the primary antibodies. Its included to verify GalNAc has not altered surface expression of MUC1\",\n  \"answer_letter\": \"C\"\n}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Examining Antibody Necessity**\n\nI'm focused on the necessity of the anti-flag antibody within this experimental context. Considering the MUC1 target, I'm evaluating how the flag tag facilitates detection, given the TN antigen modification. The key is understanding when the tag is added and how it benefits the experiment. I'm building a concise justification for the antibody's use.\n\n\n**Clarifying Antibody Roles**\n\nI'm now zeroing in on why the anti-flag antibody is indispensable, beyond confirming MUC1 surface presence, especially considering the GalNAc concentration effects. I'm exploring whether the anti-flag serves as a crucial control for the experiment's inhibitory conditions. I'm carefully assessing its timing within the process.\n\n\n**Defining Antibody Application Time**\n\nI'm now contemplating when the anti-flag antibody is best employed in this experiment. Based on the experimental setup, I'm leaning towards the anti-flag being a critical control for MUC1 surface expression or conformation, especially given the high GalNAc concentration. Thus, it should be added alongside the primary antibodies to verify MUC1 presence, not with the secondaries.\n\n\n**Refining Antibody Timing**\n\nI'm now prioritizing the optimal timing of the anti-flag antibody application, considering the influence of high GalNAc concentrations. Option C resonates, as it directly addresses potential changes in MUC1's surface expression or conformation. The goal is to separate the specific effect on the TN antigen from overall MUC1 changes. I'm focusing on when the anti-flag will offer the most definitive control.\n\n\n**Evaluating GalNAc Influence**\n\nI'm now determining why the anti-flag antibody is critical, especially when assessing the impact of high GalNAc concentrations on MUC1. The goal is to verify the MUC1 target's presence and whether GalNAc affects the antibody binding. I'm focusing on validating the MUC1 surface integrity.\n\n\n**Prioritizing Experimental Rationale**\n\nI'm now focusing on why the anti-flag antibody is indispensable, especially given the high GalNAc concentration and the TN antigen modification on MUC1. Considering the experiment\u2019s design, I believe its application is crucial to ensure that MUC1 is present and accessible on the cell surface. I'm choosing the best option.\n\n\n",
            "reasoning_details": [
              {
                "type": "reasoning.text",
                "text": "**Examining Antibody Necessity**\n\nI'm focused on the necessity of the anti-flag antibody within this experimental context. Considering the MUC1 target, I'm evaluating how the flag tag facilitates detection, given the TN antigen modification. The key is understanding when the tag is added and how it benefits the experiment. I'm building a concise justification for the antibody's use.\n\n\n**Clarifying Antibody Roles**\n\nI'm now zeroing in on why the anti-flag antibody is indispensable, beyond confirming MUC1 surface presence, especially considering the GalNAc concentration effects. I'm exploring whether the anti-flag serves as a crucial control for the experiment's inhibitory conditions. I'm carefully assessing its timing within the process.\n\n\n**Defining Antibody Application Time**\n\nI'm now contemplating when the anti-flag antibody is best employed in this experiment. Based on the experimental setup, I'm leaning towards the anti-flag being a critical control for MUC1 surface expression or conformation, especially given the high GalNAc concentration. Thus, it should be added alongside the primary antibodies to verify MUC1 presence, not with the secondaries.\n\n\n**Refining Antibody Timing**\n\nI'm now prioritizing the optimal timing of the anti-flag antibody application, considering the influence of high GalNAc concentrations. Option C resonates, as it directly addresses potential changes in MUC1's surface expression or conformation. The goal is to separate the specific effect on the TN antigen from overall MUC1 changes. I'm focusing on when the anti-flag will offer the most definitive control.\n\n\n**Evaluating GalNAc Influence**\n\nI'm now determining why the anti-flag antibody is critical, especially when assessing the impact of high GalNAc concentrations on MUC1. The goal is to verify the MUC1 target's presence and whether GalNAc affects the antibody binding. I'm focusing on validating the MUC1 surface integrity.\n\n\n**Prioritizing Experimental Rationale**\n\nI'm now focusing on why the anti-flag antibody is indispensable, especially given the high GalNAc concentration and the TN antigen modification on MUC1. Considering the experiment\u2019s design, I believe its application is crucial to ensure that MUC1 is present and accessible on the cell surface. I'm choosing the best option.\n\n\n",
                "format": "unknown",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "STOP"
        }
      ],
      "created": 1762217067,
      "model": "google/gemini-2.5-flash",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 1201,
        "prompt_tokens": 337,
        "total_tokens": 1538,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 1154,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.003072564,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 0.0001011,
          "upstream_inference_completions_cost": 0.0030025
        }
      },
      "provider": "Google"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "google/gemini-2.5-flash",
      "messages": [
        {
          "role": "user",
          "content": "The targets of some antibodies are proteo-glycans. One such antibody binds MUC1, but only if the threonine within one of MUC1's repeat sequences, GSTA, carries a TN antigen, a monosacharide of N-acetylgalactosamine. \nUsing published tools, you start to put together a system to study this antibody. Your MUC1 construct carries a flag tag and is expressed on the surface of C1GALT1 KO HEK293t cells that strictly produce TN O-glycans.  You were able to show that the sugar is essential to the interaction by using inhibitory concentrations of GalNAc (500 mM), as GalNAc inhibits the antibody's ability to bind when compared to PBS controls. In addition to verifying the surface expression of MUC1, why is it essential to include the anti-flag antibody, and to which step should it be added?\n\n\nAnswer Choices:\nA. No need, controls are good\nB. Anti-flag should be added with the secondary antibodies. Its included to control for potential off-target effects of the 500 mM GalNAc.\nC. Anti-flag should be added with the primary antibodies. Its included to verify GalNAc has not altered surface expression of MUC1\nD. Anti-flag should be added with the primary antibodies. Its included to control for potential off-target effects of the 500 mM GalNAc. \nE. Anti-flag should be added with the secondary antibodies. Its included to verify GalNAc has not altered surface expression of MUC1"
        }
      ],
      "reasoning": {
        "max_tokens": 8192
      },
      "reasoning_effort": null,
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762217067-0tgnSucKn6xvkN2eIc9X",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\n  \"answer\": \"Anti-flag should be added with the primary antibodies. Its included to verify GalNAc has not altered surface expression of MUC1\",\n  \"answer_letter\": \"C\"\n}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Defining Antibody Purpose**\n\nI'm currently focused on the purpose of including an anti-flag antibody in this experiment. Initially, I'll need to dissect the experimental setup, particularly focusing on the role of MUC1 and its glycosylation state. The antibody's function hinges on identifying the TN antigen, so I'm honing in on the conditions necessary for that.\n\n\n**Investigating Antibody Function**\n\nI'm now zeroing in on why the anti-flag antibody is indispensable, beyond just validating MUC1 surface expression. The experimental design features GalNAc inhibition, and I'm assessing if the high GalNAc concentration might cause off-target effects. That could impact the antibody's role.\n\n\n**Determining Essential Function**\n\nI'm now zeroing in on why the anti-flag antibody is indispensable, beyond just validating MUC1 surface expression, after assessing existing options. The anti-flag antibody serves to confirm if the GalNAc treatment impacts MUC1 surface expression or localization. This is a critical factor for interpreting results related to the experimental antibody's binding.\n\n\n**Choosing Crucial Function**\n\nI'm now zeroing in on why the anti-flag antibody is indispensable, beyond validating MUC1 surface expression. Based on the analysis, I've concluded that it is crucial for verifying that the high GalNAc concentration does not alter MUC1 surface expression. This confirmation is vital for accurate interpretation.\n\n\n**Choosing The Best Justification**\n\nI am now thoroughly evaluating the answers, looking for the most accurate step. The timing of the antibody is primary antibody, added before the GalNAc. I've ruled out the incorrect timing options. I'm choosing between C and D, the most likely answers. I must confirm GalNAc's effects on MUC1 surface presence. This step will help with correct data interpretation. Therefore, I will choose C as it specifies this critical control.\n\n\n",
            "reasoning_details": [
              {
                "type": "reasoning.text",
                "text": "**Defining Antibody Purpose**\n\nI'm currently focused on the purpose of including an anti-flag antibody in this experiment. Initially, I'll need to dissect the experimental setup, particularly focusing on the role of MUC1 and its glycosylation state. The antibody's function hinges on identifying the TN antigen, so I'm honing in on the conditions necessary for that.\n\n\n**Investigating Antibody Function**\n\nI'm now zeroing in on why the anti-flag antibody is indispensable, beyond just validating MUC1 surface expression. The experimental design features GalNAc inhibition, and I'm assessing if the high GalNAc concentration might cause off-target effects. That could impact the antibody's role.\n\n\n**Determining Essential Function**\n\nI'm now zeroing in on why the anti-flag antibody is indispensable, beyond just validating MUC1 surface expression, after assessing existing options. The anti-flag antibody serves to confirm if the GalNAc treatment impacts MUC1 surface expression or localization. This is a critical factor for interpreting results related to the experimental antibody's binding.\n\n\n**Choosing Crucial Function**\n\nI'm now zeroing in on why the anti-flag antibody is indispensable, beyond validating MUC1 surface expression. Based on the analysis, I've concluded that it is crucial for verifying that the high GalNAc concentration does not alter MUC1 surface expression. This confirmation is vital for accurate interpretation.\n\n\n**Choosing The Best Justification**\n\nI am now thoroughly evaluating the answers, looking for the most accurate step. The timing of the antibody is primary antibody, added before the GalNAc. I've ruled out the incorrect timing options. I'm choosing between C and D, the most likely answers. I must confirm GalNAc's effects on MUC1 surface presence. This step will help with correct data interpretation. Therefore, I will choose C as it specifies this critical control.\n\n\n",
                "format": "unknown",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "STOP"
        }
      ],
      "created": 1762217067,
      "model": "google/gemini-2.5-flash",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 1145,
        "prompt_tokens": 337,
        "total_tokens": 1482,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 1098,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.002933964,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 0.0001011,
          "upstream_inference_completions_cost": 0.0028625
        }
      },
      "provider": "Google"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "google/gemini-2.5-flash",
      "messages": [
        {
          "role": "user",
          "content": "The targets of some antibodies are proteo-glycans. One such antibody binds MUC1, but only if the threonine within one of MUC1's repeat sequences, GSTA, carries a TN antigen, a monosacharide of N-acetylgalactosamine. \nUsing published tools, you start to put together a system to study this antibody. Your MUC1 construct carries a flag tag and is expressed on the surface of C1GALT1 KO HEK293t cells that strictly produce TN O-glycans.  You were able to show that the sugar is essential to the interaction by using inhibitory concentrations of GalNAc (500 mM), as GalNAc inhibits the antibody's ability to bind when compared to PBS controls. In addition to verifying the surface expression of MUC1, why is it essential to include the anti-flag antibody, and to which step should it be added?\n\n\nAnswer Choices:\nA. No need, controls are good\nB. Anti-flag should be added with the secondary antibodies. Its included to control for potential off-target effects of the 500 mM GalNAc.\nC. Anti-flag should be added with the primary antibodies. Its included to verify GalNAc has not altered surface expression of MUC1\nD. Anti-flag should be added with the primary antibodies. Its included to control for potential off-target effects of the 500 mM GalNAc. \nE. Anti-flag should be added with the secondary antibodies. Its included to verify GalNAc has not altered surface expression of MUC1"
        }
      ],
      "reasoning": {
        "max_tokens": 8192
      },
      "reasoning_effort": null,
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762217067-5aOMSZeEKXwM5lF99bbt",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\n  \"answer\": \"Anti-flag should be added with the primary antibodies. Its included to verify GalNAc has not altered surface expression of MUC1\",\n  \"answer_letter\": \"C\"\n}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Defining Antibody Roles**\n\nI'm currently focused on the essential function of the anti-flag antibody in this experiment. My understanding is that it's crucial for detection. Specifically, I am considering the optimal timing for its introduction to the experiment, based on the protocol, so as to avoid any disruption to the process. I am determining how it works in conjunction with the other antibodies and control mechanisms in place.\n\n\n**Evaluating Anti-Flag's Importance**\n\nI'm now investigating why the anti-flag antibody is indispensable, beyond confirming MUC1's presence. I am realizing that by using it, I can confirm the protein's surface expression, regardless of the glycan. I am considering that by using the anti-flag antibody first, I can use it as a control to measure the expression of the target protein.\n\n\n**Clarifying Anti-Flag's Function**\n\nMy thinking has progressed to the core reason for using the anti-flag antibody. It's essentially a control. The goal is to determine the specificity of the antibody binding MUC1. The anti-flag antibody confirms that MUC1 is present on the cell surface, unaffected by GalNAc. By using it in parallel with the MUC1-binding antibody, I can validate that any changes observed in MUC1 binding are due to glycan modification, not protein loss.\n\n\n**Pinpointing Antibody Application**\n\nI am now focusing on the optimal timing for the anti-flag antibody. I've concluded it needs to be added with the primary antibodies to verify MUC1's presence on the cell surface. This is vital to confirm that any binding changes of the MUC1-binding antibody are specifically due to glycan modification by GalNAc, and not due to the absence of the MUC1 protein.\n\n\n**Defining Flag Antibody Timing**\n\nI'm now fully focused on the anti-flag antibody's experimental timing and purpose. Considering the primary antibody's role, I have determined it must be added with those to verify MUC1 presence, unaffected by GalNAc. By doing so, I will validate the impact of glycan modification.\n\n\n**Confirming MUC1's Accessibility**\n\nI'm now zeroing in on why the anti-flag antibody is indispensable, beyond simply proving MUC1's presence. I've realized its crucial function lies in validating the accessibility of MUC1 on the cell surface, unaffected by the GalNAc treatment. Considering this, the timing with the primary antibodies is key, especially given how the results can be used for drawing conclusions.\n\n\n",
            "reasoning_details": [
              {
                "type": "reasoning.text",
                "text": "**Defining Antibody Roles**\n\nI'm currently focused on the essential function of the anti-flag antibody in this experiment. My understanding is that it's crucial for detection. Specifically, I am considering the optimal timing for its introduction to the experiment, based on the protocol, so as to avoid any disruption to the process. I am determining how it works in conjunction with the other antibodies and control mechanisms in place.\n\n\n**Evaluating Anti-Flag's Importance**\n\nI'm now investigating why the anti-flag antibody is indispensable, beyond confirming MUC1's presence. I am realizing that by using it, I can confirm the protein's surface expression, regardless of the glycan. I am considering that by using the anti-flag antibody first, I can use it as a control to measure the expression of the target protein.\n\n\n**Clarifying Anti-Flag's Function**\n\nMy thinking has progressed to the core reason for using the anti-flag antibody. It's essentially a control. The goal is to determine the specificity of the antibody binding MUC1. The anti-flag antibody confirms that MUC1 is present on the cell surface, unaffected by GalNAc. By using it in parallel with the MUC1-binding antibody, I can validate that any changes observed in MUC1 binding are due to glycan modification, not protein loss.\n\n\n**Pinpointing Antibody Application**\n\nI am now focusing on the optimal timing for the anti-flag antibody. I've concluded it needs to be added with the primary antibodies to verify MUC1's presence on the cell surface. This is vital to confirm that any binding changes of the MUC1-binding antibody are specifically due to glycan modification by GalNAc, and not due to the absence of the MUC1 protein.\n\n\n**Defining Flag Antibody Timing**\n\nI'm now fully focused on the anti-flag antibody's experimental timing and purpose. Considering the primary antibody's role, I have determined it must be added with those to verify MUC1 presence, unaffected by GalNAc. By doing so, I will validate the impact of glycan modification.\n\n\n**Confirming MUC1's Accessibility**\n\nI'm now zeroing in on why the anti-flag antibody is indispensable, beyond simply proving MUC1's presence. I've realized its crucial function lies in validating the accessibility of MUC1 on the cell surface, unaffected by the GalNAc treatment. Considering this, the timing with the primary antibodies is key, especially given how the results can be used for drawing conclusions.\n\n\n",
                "format": "unknown",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "STOP"
        }
      ],
      "created": 1762217067,
      "model": "google/gemini-2.5-flash",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 1300,
        "prompt_tokens": 337,
        "total_tokens": 1637,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 1253,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.003317589,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 0.0001011,
          "upstream_inference_completions_cost": 0.00325
        }
      },
      "provider": "Google"
    }
  }
]